These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth. Manuck TA, Esplin MS, Biggio J, Bukowski R, Parry S, Zhang H, Huang H, Varner MW, Andrews W, Saade G, Sadovsky Y, Reddy UM, Ilekis J, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Genomics and Proteomics Network for Preterm Birth Research (GPN-PBR). Am J Obstet Gynecol; 2016 Mar; 214(3):376.e1-8. PubMed ID: 26692181 [Abstract] [Full Text] [Related]
16. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial. Boelig RC, Schoen CN, Frey H, Gimovsky AC, Springel E, Backley S, Berghella V. Am J Obstet Gynecol; 2022 May; 226(5):722.e1-722.e12. PubMed ID: 35189093 [Abstract] [Full Text] [Related]
17. Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial. Martinez de Tejada B, Karolinski A, Ocampo MC, Laterra C, Hösli I, Fernández D, Surbek D, Huespe M, Drack G, Bunader A, Rouillier S, López de Degani G, Seidenstein E, Prentl E, Antón J, Krähenmann F, Nowacki D, Poncelas M, Nassif JC, Papera R, Tuma C, Espoile R, Tiberio O, Breccia G, Messina A, Peker B, Schinner E, Mol BW, Kanterewicz L, Wainer V, Boulvain M, Othenin-Girard V, Bertolino MV, Irion O, 4P trial group. BJOG; 2015 Jan; 122(1):80-91. PubMed ID: 25209926 [Abstract] [Full Text] [Related]
20. 17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial. Combs CA, Garite T, Maurel K, Das A, Porto M, Obstetrix Collaborative Research Network. Am J Obstet Gynecol; 2011 Mar; 204(3):221.e1-8. PubMed ID: 21376161 [Abstract] [Full Text] [Related] Page: [Next] [New Search]